A supplier that answers analytical questions with restated claims — setting out what I have, and where I think it stops being reliable.
A follow-up question about supplier that I did not know to ask the first time.
The earlier thread answered what I asked. What I should have asked is below, and I think it is the one that matters.
I read the opening post twice before replying, because I had assumed the opposite.
Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
Old habit: I write down the expected answer before I calculate it.
Supplier is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Saving this. It is the version I will quote when the question comes round again.
Narrowing post #6, because the general version has more than one answer.
Claims of pharmaceutical-grade status for research-use-only material are a labelling problem and are common enough to be worth expecting rather than reacting to.
An unexplained discrepancy that the supplier declined to address is a legitimate thing to record, stated as exactly that and nothing more.
I would want to see it done twice before believing it once.
Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation about intent and nothing in a chromatogram supports it.
Reading it back, the second half matters more than the first.
Post #8 is right about the mechanism and I think understates the practical bit.
Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
Anyone who has looked at this more carefully, please correct the record.
On supplier, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
A supplier changing batch nomenclature is not a warning sign, and it does make historical comparison harder until a mapping exists.
Post #12 answers the question as asked. The question underneath it is different.
The number people quote for supplier is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on its own.
Being wrong in public about a supplier is costly to that supplier and to the person who was wrong. That is why the evidence standard is what it is.
Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you something about systems behind the document. A certificate that is a number and a signature tells you less.
That is one dataset and I would not build a rule on it.
A definition problem is doing most of the work in this supplier discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is small.
The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at scale.
Second-hand, so weight it accordingly.
On supplier, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.
If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.
Worth separating two things that post #19 runs together.
I would rather this thread reach "we do not know" about supplier than reach a confident answer that nobody can support when asked.
This follows post #23 rather than contradicting it.
Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
Posting it because the silence on this was starting to look like agreement.
Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth documenting.
Post #23 and I disagree about the size of the effect, not about the direction.
What would change my mind on supplier is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.
Where I part company with post #27, and it is a narrow parting.
Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and legitimacy.
Post #27 is the version of this I will quote in future. One addition.
Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming implausible perfection without backing evidence is overreaching.
This is where my knowledge stops and I would rather mark the edge than blur it.